Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery

Patient drug regime compliance is a major issue; sustained release implants could address this. Here, the authors report on a phase inverted in situ forming implant of PLGA for the sustained release of antiretroviral drugs and optimize and demonstrate the release of 6 different drugs over a period o...

Full description

Bibliographic Details
Main Authors: S. Rahima Benhabbour, Martina Kovarova, Clinton Jones, Daijha J. Copeland, Roopali Shrivastava, Michael D. Swanson, Craig Sykes, Phong T. Ho, Mackenzie L. Cottrell, Anush Sridharan, Samantha M. Fix, Orrin Thayer, Julie M. Long, Daria J. Hazuda, Paul A. Dayton, Russell J. Mumper, Angela D. M. Kashuba, J. Victor Garcia
Format: Article
Language:English
Published: Nature Publishing Group 2019-09-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-019-12141-5
id doaj-8bc4a989ec17413397ece8fc45f93686
record_format Article
spelling doaj-8bc4a989ec17413397ece8fc45f936862021-05-11T12:30:35ZengNature Publishing GroupNature Communications2041-17232019-09-0110111210.1038/s41467-019-12141-5Ultra-long-acting tunable biodegradable and removable controlled release implants for drug deliveryS. Rahima Benhabbour0Martina Kovarova1Clinton Jones2Daijha J. Copeland3Roopali Shrivastava4Michael D. Swanson5Craig Sykes6Phong T. Ho7Mackenzie L. Cottrell8Anush Sridharan9Samantha M. Fix10Orrin Thayer11Julie M. Long12Daria J. Hazuda13Paul A. Dayton14Russell J. Mumper15Angela D. M. Kashuba16J. Victor Garcia17UNC_NCSU Joint Department of Biomedical Engineering, University of North Carolina at Chapel HillInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for Aids Research, School of Medicine, University of North Carolina at Chapel HillUNC Eshelman School of Pharmacy, Division of Pharmacoengineering and Molecular PharmaceuticsUNC Eshelman School of Pharmacy, Division of Pharmacoengineering and Molecular PharmaceuticsUNC_NCSU Joint Department of Biomedical Engineering, University of North Carolina at Chapel HillInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for Aids Research, School of Medicine, University of North Carolina at Chapel HillDivision of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel HillInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for Aids Research, School of Medicine, University of North Carolina at Chapel HillInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for Aids Research, School of Medicine, University of North Carolina at Chapel HillUNC_NCSU Joint Department of Biomedical Engineering, University of North Carolina at Chapel HillUNC Eshelman School of Pharmacy, Division of Pharmacoengineering and Molecular PharmaceuticsInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for Aids Research, School of Medicine, University of North Carolina at Chapel HillInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for Aids Research, School of Medicine, University of North Carolina at Chapel HillInfectious Disease Biology, Merck Research LaboratoriesUNC_NCSU Joint Department of Biomedical Engineering, University of North Carolina at Chapel HillUniversity of Georgia, Office of the ProvostDivision of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel HillInternational Center for the Advancement of Translational Science, Division of Infectious Diseases, Center for Aids Research, School of Medicine, University of North Carolina at Chapel HillPatient drug regime compliance is a major issue; sustained release implants could address this. Here, the authors report on a phase inverted in situ forming implant of PLGA for the sustained release of antiretroviral drugs and optimize and demonstrate the release of 6 different drugs over a period of up to a year.https://doi.org/10.1038/s41467-019-12141-5
collection DOAJ
language English
format Article
sources DOAJ
author S. Rahima Benhabbour
Martina Kovarova
Clinton Jones
Daijha J. Copeland
Roopali Shrivastava
Michael D. Swanson
Craig Sykes
Phong T. Ho
Mackenzie L. Cottrell
Anush Sridharan
Samantha M. Fix
Orrin Thayer
Julie M. Long
Daria J. Hazuda
Paul A. Dayton
Russell J. Mumper
Angela D. M. Kashuba
J. Victor Garcia
spellingShingle S. Rahima Benhabbour
Martina Kovarova
Clinton Jones
Daijha J. Copeland
Roopali Shrivastava
Michael D. Swanson
Craig Sykes
Phong T. Ho
Mackenzie L. Cottrell
Anush Sridharan
Samantha M. Fix
Orrin Thayer
Julie M. Long
Daria J. Hazuda
Paul A. Dayton
Russell J. Mumper
Angela D. M. Kashuba
J. Victor Garcia
Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
Nature Communications
author_facet S. Rahima Benhabbour
Martina Kovarova
Clinton Jones
Daijha J. Copeland
Roopali Shrivastava
Michael D. Swanson
Craig Sykes
Phong T. Ho
Mackenzie L. Cottrell
Anush Sridharan
Samantha M. Fix
Orrin Thayer
Julie M. Long
Daria J. Hazuda
Paul A. Dayton
Russell J. Mumper
Angela D. M. Kashuba
J. Victor Garcia
author_sort S. Rahima Benhabbour
title Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
title_short Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
title_full Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
title_fullStr Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
title_full_unstemmed Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
title_sort ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2019-09-01
description Patient drug regime compliance is a major issue; sustained release implants could address this. Here, the authors report on a phase inverted in situ forming implant of PLGA for the sustained release of antiretroviral drugs and optimize and demonstrate the release of 6 different drugs over a period of up to a year.
url https://doi.org/10.1038/s41467-019-12141-5
work_keys_str_mv AT srahimabenhabbour ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT martinakovarova ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT clintonjones ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT daijhajcopeland ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT roopalishrivastava ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT michaeldswanson ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT craigsykes ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT phongtho ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT mackenzielcottrell ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT anushsridharan ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT samanthamfix ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT orrinthayer ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT juliemlong ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT dariajhazuda ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT pauladayton ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT russelljmumper ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT angeladmkashuba ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
AT jvictorgarcia ultralongactingtunablebiodegradableandremovablecontrolledreleaseimplantsfordrugdelivery
_version_ 1721444722125307904